FDA should encourage states to be the primary regulators of stem cell procedures.
Expert argues that federal law gives regulator authority to restrict unauthorized drug uses.
Lawyer argues that United States should ramp up regulation of dietary supplements.
Legal scholar argues for greater reliance on entrepreneurial strategies in regulation.
Scholar argues U.S.-China trade agreements fill regulatory gaps left by both countries.
Legal scholar reexamines the formal rulemaking process in response to criticism.
Regulatory reform bill’s public hearing requirement will hinder agencies’ attempts to regulate.
Legal scholar argues that the oft-criticized formal rulemaking process has virtues in proper settings.
Scholar argues that governments should embrace vaping’s smoking-cessation potential.
Amid growing concerns about “superbugs,” regulators seek comment on use of antimicrobials in animal feed.
FDA is years behind in its statutory mandate to put graphic warnings on cigarette labels.
Scholar argues that regulators will have difficulty applying cost-benefit analysis to mandatory GMO labeling.